A pharmacist reported via an (b)(4) sales representative that a (b)(6) year old female patient started abilify maintena (aripiprazole) 400 mg, frequency unknown on an unknown date for schizophrenia.She also started carbamazepine, unknown dose and frequency on an unknown date for schizophrenia.The patient has no relevant medical history.The patient's relevant concomitant medications and past drug history are unknown.The patient was prescribed both medications by a provider she was seeing on an out-patient basis at a hospital.On (b)(6) 2014, sometime after her third injection, she was admitted to a different psychiatric hospital for breakthrough symptoms.The pharmacist realized that the patient had been taking the abilify maintena and the carbamazepine together and should not have been.She was discontinued from the carbamazepine.On (b)(6) 2014, at 5 pm, she received her 4th injection of the abilify maintena while still in the psychiatric hospital.At 5 am, on (b)(6) 2014, she had a pulmonary emboli and was rushed to a medical hospital, at 7 am on (b)(6) 2014, she passed away.
|